Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 62.51 +2.80%   SPY: 131.97 +1.72%
Quote Spy CYCCP NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.


6% Convertible Exchangeable Preferred Stock (CYCCP)

@ May-18
Click the portfolio to add CYCCP:
Close [X]
+ Add CYCCP to Portfolio
  
  Last Trade: $2.51 0.00 (0.00%)
  Volume:
       
  Avg Volume: 172
3-Month Chart (Larger chart w/volume)
Close [X]
1m  3m  6m  1y  2y
  Day's Range: 0.00 - 0.00
  Open: 0.00
  Previous Close: 2.51
  52-wk Range: 2.35 - 4.52
  Market Cap:
  P/E: 0.0
  Div Yield: $0.15 (0.00%)
Indexes
None
Spy CYCCP

? Pro holders
? Member holders
? Items submitted
Additional CYCCP resources



Customize Links
To see which Pros and tickerspy members own CYCCP Sign up now
Latest CYCCP Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

Cyclacel to Report New Sapacitabine Clinical Data at the American Society of Clinical Oncology Annual Meeting
CYCC  CYCCP  
Linked by GlobeNewswire - May 17, 07:00AM from (www.globenewswire.com)
BERKELEY HEIGHTS, N.J., May 17, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Cyclacel Reports First Quarter 2012 Financial Results
CYCC  CYCCP  
Linked by GlobeNewswire - May 14, 04:01PM from (www.globenewswire.com)
BERKELEY HEIGHTS, N.J., May 14, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP); (Cyclacel  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Cyclacel Announces Completion of Enrollment in Investigator-Initiated, Phase 2/3 Randomized Trial Comparing Sapacitabine to Low Dose Cytarabine
CYCC  CYCCP  
Linked by GlobeNewswire - May 14, 07:00AM from (www.globenewswire.com)
BERKELEY HEIGHTS, N.J., May 14, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel"  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Cyclacel Pharmaceuticals to Announce Release of First Quarter 2012 Financial Results
CYCC  CYCCP  
Linked by GlobeNewswire - May 08, 07:00AM from (www.globenewswire.com)
BERKELEY HEIGHTS, N.J., May 8, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP); (Cyclacel  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Cyclacel Pharmaceuticals Announces Grant of New U.S. Patent Covering Sapacitabine
CYCC  CYCCP  
Linked by GlobeNewswire - April 17, 07:00AM from (www.globenewswire.com)
BERKELEY HEIGHTS, N.J., April 17, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP); (Cyclacel  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Personalized Medicine and Combination Potential of Cyclacel's Sapacitabine Highlighted at AACR
CYCC  CYCCP  
Linked by GlobeNewswire - April 04, 09:00AM from (www.globenewswire.com)
BERKELEY HEIGHTS, N.J., April 4, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP); (Cyclacel  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Cyclacel's Novel Polo-Like Kinase 1 (Plk1) Inhibitors Highlighted at AACR
CYCC  CYCCP  
Linked by GlobeNewswire - April 02, 02:00PM from (www.globenewswire.com)
BERKELEY HEIGHTS, N.J., April 2, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2011 Financial Results
CYCC  CYCCP  
Linked by GlobeNewswire - March 29, 04:01PM from (www.globenewswire.com)
BERKELEY HEIGHTS, N.J., March 29, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel"  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Cyclacel to Announce Year-End and Fourth Quarter 2011 Financial Results and Multiple Presentations at the Upcoming AACR Conference
CYCC  CYCCP  
Linked by GlobeNewswire - March 26, 04:30PM from (www.globenewswire.com)
BERKELEY HEIGHTS, N.J., March 26, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel"  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Cyclacel Announces $3.0 Million Financing to Fund Ongoing Litigation Expenses on Certain Intellectual Property
CYCC  CYCCP  
Linked by GlobeNewswire - March 22, 04:30PM from (www.globenewswire.com)
BERKELEY HEIGHTS, N.J., March 22, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel"  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6 7



Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource